Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 11 (2) , 391-400
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81102386)
- Fudan University
- National Key Research and Development Program of China (2013CB932502, 81361140344)
- Specialized Research Fund for the Doctoral Program of Higher Education of China (20110071120042)
This publication has 31 references indexed in Scilit:
- The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytesJournal of Leukocyte Biology, 2012
- PI3K/Akt Signaling Pathway in the Basolateral Amygdala Mediates the Rapid Antidepressant-like Effects of Trefoil Factor 3Neuropsychopharmacology, 2012
- Modern methods for delivery of drugs across the blood–brain barrierAdvanced Drug Delivery Reviews, 2012
- Delivery of peptide and protein drugs over the blood–brain barrierProgress in Neurobiology, 2009
- Strategies to advance translational research into brain barriersThe Lancet Neurology, 2008
- TFF3 induced Fos protein expression in the magnocellular oxytocin neurons of the hypothalamusPeptides, 2004
- The Epidemiology of Major Depressive DisorderJAMA, 2003
- Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the ratGut, 1998
- The blood-brain barrier and the inflammatory responseMolecular Medicine Today, 1997
- Characterization of Human and Rat Intestinal Trefoil Factor Produced in YeastBiochemistry, 1995